ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NBSE NeuBase Therapeutics Inc

0.3891
-0.023 (-5.58%)
May 03 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Jun 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -8.88M-7.3M-7.72M-9.93M-8.36M-7.72M-4.6M-3.69M
Pre Tax Income -8.66M-7.16M-7.73M-9.92M-8.49M-7.63M-4.37M-3.45M
Net Income -8.66M-7.16M-7.73M-9.92M-8.49M-7.63M-4.37M-3.45M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.88M-7.16M-7.72M-9.92M-8.52M-7.74M-4.52M-4.99M
EBITDA -8.78M-7.15M-7.54M-9.71M-8.16M-7.56M-4.4M-3.51M
Year End September 29 2022 20152016201720182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0710k71k1.23M0000
Operating Income -17.81M-24.6M-23.78M-13.9M-26.34M-17.33M-26.79M-33.73M
Pre Tax Income -15.2M-25.77M-23.81M-13.24M-26.96M-17.39M-25.41M-33.78M
Net Income -15.2M-25.77M-23.81M-13.24M-26.96M-17.39M-25.41M-33.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.501-0.803-0.424-0.234-1.579-0.751-0.777-1.023
EBIT -15.19M-25.78M-23.78M-13.31M-26.34M-16.92M-26.34M-33.9M
EBITDA -16.29M-23.41M-22.61M-6.72M-26.21M-17.13M-26.39M-32.97M

Your Recent History

Delayed Upgrade Clock